Merck & Co., which paid $4.85 billion to resolve lawsuits contending its Vioxx painkiller caused heart attacks, will pay another $23 million to settle claims it duped consumers into buying the drug.

VIOXX was launched in the United States in 1999 and has been marketed in more than ... The results of clinical studies with one molecule in a given class are not necessarily applicable to others ...

Drugmaker Merck withdrew its painkiller Vioxx from the market in 2004 after a study showed the drug increased patients' risk of heart attacks and strokes. An estimated 20 million Americans had ...

Madeleine Brand talks to Bob Moon of Marketplace about a major victory for drug maker Merck. A jury on Thursday found the company adequately warned consumers about the risks of their painkiller Vioxx.

Merck stopped selling Vioxx in 2004 after evidence showed the drug doubled the risk of heart attack and stroke. In 2007, the company paid $4.85 billion to settle around 50,000 Vioxx-related lawsuits.

The Food and Drug Administration (FDA) estimates that Vioxx may have contributed to 27,785 heart attacks and sudden cardiac deaths between 1999 and 2003. Trending Trending ...

A long-term analysis of people who took the arthritis drug Vioxx confirms it doubles the risk of strokes and heart attacks, researchers said on Monday, but this risk goes away a year after people ...

Merck is closing a chapter in its seemingly never-ending saga for its painkiller Vioxx, agreeing to pay more than $800 million to settle a lawsuit over the med years after the company pulled its ...

Merck will pay $830 million to resolve a federal class-action lawsuit involving shareholders and the painkiller Vioxx, which the drugmaker pulled from the market years ago over safety concerns. ...

The cardiologist for a man who sued Merck & Co. Inc. (MRK), blaming Vioxx for his 2001 heart attack, testified Thursday that the withdrawn painkiller and not heart disease was likely responsible.